Artificial Tissue Chips Market, Global Outlook and Forecast 2025-2031

Global Artificial Tissue Chips market was valued at approximately USD 156 million in 2024 and is projected to reach USD 824 million by 2031, growing at a compound annual growth rate (CAGR) of 27.5%

PDF Icon Download Sample Report PDF

  • Quick Dispatch

    All Orders

  • Secure Payment

    100% Secure Payment

Compare

$1,500.00 – $4,250.00

Clear

Artificial Tissue Chips Market Analysis:

The global Artificial Tissue Chips market was valued at approximately USD 156 million in 2024 and is projected to reach USD 824 million by 2031, growing at a compound annual growth rate (CAGR) of 27.5% during the forecast period. The increasing demand for alternatives to animal testing in drug development, toxicity testing, and personalized medicine is driving this market. The technology’s potential to simulate human organs and systems for research and testing purposes is a key factor behind its rapid adoption.

Artificial Tissue Chips Market Overview:

Artificial Tissue Chips are 3D microfluidic devices that mimic the physiological functions and mechanics of human organs or organ systems. These chips allow for the study of human biology in a highly controlled and accurate environment, which could one day replace animal testing in biomedical research. The technology’s ability to simulate multiple organ systems in a small-scale, high-throughput format makes it an essential tool for drug discovery, toxicology studies, and disease modeling.

Artificial Tissue Chips Key Market Trends:

  1. Rise in Demand for In Vitro Models: The push for more ethical, reliable, and cost-effective alternatives to animal testing is a major factor contributing to the growth of the Artificial Tissue Chips market.

  2. Technological Advancements: The ongoing development of more complex and multi-organ chips is expanding the scope of tissue chip applications, allowing for more comprehensive testing of drug interactions and disease progression.

  3. Government Support and Funding: Various governments and regulatory bodies are investing in research and development in the field of tissue chips, particularly in the context of creating alternatives to animal testing.

  4. Applications in Personalized Medicine: Artificial Tissue Chips are playing a significant role in the growing field of personalized medicine, where drugs can be tested on tissue chips made from a patient’s own cells, leading to more targeted treatments.

Artificial Tissue Chips Market Regional Analysis:

  • North America: North America dominates the market due to the presence of key players, substantial funding for research and development, and a robust pharmaceutical industry. The U.S. is the largest contributor, followed by Canada and Mexico.

  • Europe: Europe is witnessing significant growth in the market, with countries like Germany, France, and the U.K. leading the way in research and development for innovative tissue chip solutions.

  • Asia-Pacific: The Asia-Pacific region is expanding rapidly in the market, driven by the increasing adoption of advanced technologies in countries like China, Japan, and South Korea. The growth of pharmaceutical companies in this region is also a contributing factor.

  • South America: The South American market is smaller but growing, particularly in Brazil and Argentina, as pharmaceutical and biotechnology companies in these regions begin to adopt new technologies for drug testing and disease modeling.

  • Middle East & Africa: This region is still in the early stages of adopting tissue chip technology, with the United Arab Emirates and Saudi Arabia being key players in the market.

Total Market by Segment:

  • By Type:

    • Brain-on-a-Chip

    • Liver-on-a-Chip

    • Kidney-on-a-Chip

    • Lung-on-a-Chip

    • Heart-on-a-Chip

    • Intestine-on-a-Chip

    • Vessel-on-a-Chip

    • Others

    The segment for Brain-on-a-Chip and Liver-on-a-Chip is expected to see the highest growth due to the growing demand for these models in neurological and drug development research.

  • By Application:

    • Pharmaceutical & Biotechnology Companies

    • Academic & Research Institutes

    • Cosmetics Industry

    • Others

    Key Players by Application:

    • Pharmaceutical & Biotechnology Companies: Emulate, TissUse, Hesperos, CN Bio Innovations, Mimetas

    • Academic & Research Institutes: Emulate, TissUse, Hesperos, Mimetas, Tara Biosystems

    • Cosmetics Industry: Mimetas, Emulate, CN Bio Innovations

    Pharmaceutical and biotechnology companies are the largest contributors to market growth, using tissue chips for drug development and toxicity testing.

Competitor Analysis:

The global Artificial Tissue Chips market is highly competitive, with several key players dominating the space. These companies are leading the way in terms of innovation and expanding the market for tissue chip technology.

Key Players Include:

  • Emulate

  • TissUse

  • Hesperos

  • CN Bio Innovations

  • Tara Biosystems

  • Draper Laboratory

  • Mimetas

  • Nortis

  • Micronit Microtechnologies B.V.

  • Kirkstall

  • Cherry Biotech SAS

  • Else Kooi Laboratory

These companies are engaged in research, development, and commercialization of various tissue chip models, driving the market forward with new advancements in organ simulation technologies.

Market Drivers:

  1. Need for Alternatives to Animal Testing: Tissue chips offer an ethical alternative to animal testing, which is one of the most significant drivers of market growth.

  2. Advances in Organ-on-Chip Technology: The development of more sophisticated organ models allows for more detailed and accurate simulations of human biology, which is highly valuable for drug testing, toxicology, and disease research.

  3. Growing Pharmaceutical and Biotech Industries: As the pharmaceutical and biotechnology industries grow, there is a greater need for effective testing systems like tissue chips for drug discovery and development.

  4. Rising Investments in Biomedical Research: The increasing focus on developing personalized medicine and improving drug efficacy is boosting the demand for tissue chips in the healthcare sector.

Market Restraints:

  1. High Costs: The high cost of tissue chip technology, particularly for advanced models that simulate multiple organs, may limit widespread adoption, particularly among smaller companies or academic institutions.

  2. Complexity in Fabrication: The complexity involved in designing and manufacturing highly accurate tissue chips can slow down their development and increase production costs.

  3. Regulatory Hurdles: While tissue chips offer promising alternatives to animal testing, regulatory bodies must establish clear guidelines for their use in drug approval processes, which could take time.

Opportunities in the Market:

  1. Personalized Medicine: As the demand for personalized medicine increases, tissue chips can be used to test drugs on a patient-specific basis, creating opportunities for highly targeted treatments.

  2. Advancements in Multi-Organ Chips: The development of chips that simulate multiple organ systems could create more comprehensive models for testing drug interactions and understanding disease processes.

  3. Expanding Applications in Cosmetics: Tissue chips have the potential to replace animal testing in the cosmetics industry, presenting significant opportunities for growth in this sector.

Challenges in the Market:

  1. Technological Limitations: Despite rapid advancements, tissue chips still face technological challenges in fully replicating the complexity of human organs, which could limit their accuracy in some applications.

  2. Market Fragmentation: With several players involved in developing different types of chips, market fragmentation can make it difficult for companies to dominate and establish a strong foothold.

FAQs:

Q1: What are the key driving factors and opportunities in the market?
A1: The key driving factors in the Artificial Tissue Chips market include the increasing demand for alternative methods to animal testing, advancements in biomedical engineering, and the growing use of tissue chips in drug development and toxicity testing. Opportunities lie in expanding their application in personalized medicine, improving disease models, and reducing the cost and time involved in clinical trials.

Q2: Which region is projected to have the largest share?
A2: North America is projected to have the largest share in the Artificial Tissue Chips market, driven by strong investments in research, development, and advanced healthcare infrastructure, as well as a well-established pharmaceutical and biotechnology industry.

Q3: Who are the top players in the global market?
A3: The top players in the global Artificial Tissue Chips market include Emulate, TissUse, Hesperos, CN Bio Innovations, and Mimetas.

Q4: What are the latest technological advancements in the industry?
A4: Recent advancements in the industry include the integration of more complex organ systems in tissue chips, enhanced microfluidic technologies, and the incorporation of sensors for real-time data analysis. Innovations also include improved cell culture techniques and the development of multi-organ chips to better simulate human physiology.

Q5: What is the current size of the global market?
A5: The global Artificial Tissue Chips market was valued at $156 million in 2024 and is projected to reach $824 million by 2031, growing at a CAGR of 27.5% during the forecast period.

Artificial Tissue Chips Market, Global Outlook and Forecast 2025-2031

Get Sample Report PDF for Exclusive Insights

Report Sample Includes

  • Table of Contents
  • List of Tables & Figures
  • Charts, Research Methodology, and more...
PDF Icon Download Sample Report PDF

Download Sample Report

Table of Content

1 Introduction to Research & Analysis Reports
1.1 Artificial Tissue Chips Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Artificial Tissue Chips Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Artificial Tissue Chips Overall Market Size
2.1 Global Artificial Tissue Chips Market Size: 2024 VS 2031
2.2 Global Artificial Tissue Chips Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Artificial Tissue Chips Sales: 2020-2031
3 Company Landscape
3.1 Top Artificial Tissue Chips Players in Global Market
3.2 Top Global Artificial Tissue Chips Companies Ranked by Revenue
3.3 Global Artificial Tissue Chips Revenue by Companies
3.4 Global Artificial Tissue Chips Sales by Companies
3.5 Global Artificial Tissue Chips Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Artificial Tissue Chips Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Artificial Tissue Chips Product Type
3.8 Tier 1, Tier 2, and Tier 3 Artificial Tissue Chips Players in Global Market
3.8.1 List of Global Tier 1 Artificial Tissue Chips Companies
3.8.2 List of Global Tier 2 and Tier 3 Artificial Tissue Chips Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type – Global Artificial Tissue Chips Market Size Markets, 2024 & 2031
4.1.2 Brain-on-a-Chip
4.1.3 Liver-on-a-Chip
4.1.4 Kidney-on-a-Chip
4.1.5 Lung-on-a-Chip
4.1.6 Heart-on-a-Chip
4.1.7 Intestine-on-a-Chip
4.1.8 Vessel-on-a-Chip
4.1.9 Others
4.2 Segment by Type – Global Artificial Tissue Chips Revenue & Forecasts
4.2.1 Segment by Type – Global Artificial Tissue Chips Revenue, 2020-2025
4.2.2 Segment by Type – Global Artificial Tissue Chips Revenue, 2026-2031
4.2.3 Segment by Type – Global Artificial Tissue Chips Revenue Market Share, 2020-2031
4.3 Segment by Type – Global Artificial Tissue Chips Sales & Forecasts
4.3.1 Segment by Type – Global Artificial Tissue Chips Sales, 2020-2025
4.3.2 Segment by Type – Global Artificial Tissue Chips Sales, 2026-2031
4.3.3 Segment by Type – Global Artificial Tissue Chips Sales Market Share, 2020-2031
4.4 Segment by Type – Global Artificial Tissue Chips Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application – Global Artificial Tissue Chips Market Size, 2024 & 2031
5.1.2 Pharmaceutical & Biotechnology Companies
5.1.3 Academic & Research Institutes
5.1.4 Cosmetics Industry
5.1.5 Others
5.2 Segment by Application – Global Artificial Tissue Chips Revenue & Forecasts
5.2.1 Segment by Application – Global Artificial Tissue Chips Revenue, 2020-2025
5.2.2 Segment by Application – Global Artificial Tissue Chips Revenue, 2026-2031
5.2.3 Segment by Application – Global Artificial Tissue Chips Revenue Market Share, 2020-2031
5.3 Segment by Application – Global Artificial Tissue Chips Sales & Forecasts
5.3.1 Segment by Application – Global Artificial Tissue Chips Sales, 2020-2025
5.3.2 Segment by Application – Global Artificial Tissue Chips Sales, 2026-2031
5.3.3 Segment by Application – Global Artificial Tissue Chips Sales Market Share, 2020-2031
5.4 Segment by Application – Global Artificial Tissue Chips Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region – Global Artificial Tissue Chips Market Size, 2024 & 2031
6.2 By Region – Global Artificial Tissue Chips Revenue & Forecasts
6.2.1 By Region – Global Artificial Tissue Chips Revenue, 2020-2025
6.2.2 By Region – Global Artificial Tissue Chips Revenue, 2026-2031
6.2.3 By Region – Global Artificial Tissue Chips Revenue Market Share, 2020-2031
6.3 By Region – Global Artificial Tissue Chips Sales & Forecasts
6.3.1 By Region – Global Artificial Tissue Chips Sales, 2020-2025
6.3.2 By Region – Global Artificial Tissue Chips Sales, 2026-2031
6.3.3 By Region – Global Artificial Tissue Chips Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country – North America Artificial Tissue Chips Revenue, 2020-2031
6.4.2 By Country – North America Artificial Tissue Chips Sales, 2020-2031
6.4.3 United States Artificial Tissue Chips Market Size, 2020-2031
6.4.4 Canada Artificial Tissue Chips Market Size, 2020-2031
6.4.5 Mexico Artificial Tissue Chips Market Size, 2020-2031
6.5 Europe
6.5.1 By Country – Europe Artificial Tissue Chips Revenue, 2020-2031
6.5.2 By Country – Europe Artificial Tissue Chips Sales, 2020-2031
6.5.3 Germany Artificial Tissue Chips Market Size, 2020-2031
6.5.4 France Artificial Tissue Chips Market Size, 2020-2031
6.5.5 U.K. Artificial Tissue Chips Market Size, 2020-2031
6.5.6 Italy Artificial Tissue Chips Market Size, 2020-2031
6.5.7 Russia Artificial Tissue Chips Market Size, 2020-2031
6.5.8 Nordic Countries Artificial Tissue Chips Market Size, 2020-2031
6.5.9 Benelux Artificial Tissue Chips Market Size, 2020-2031
6.6 Asia
6.6.1 By Region – Asia Artificial Tissue Chips Revenue, 2020-2031
6.6.2 By Region – Asia Artificial Tissue Chips Sales, 2020-2031
6.6.3 China Artificial Tissue Chips Market Size, 2020-2031
6.6.4 Japan Artificial Tissue Chips Market Size, 2020-2031
6.6.5 South Korea Artificial Tissue Chips Market Size, 2020-2031
6.6.6 Southeast Asia Artificial Tissue Chips Market Size, 2020-2031
6.6.7 India Artificial Tissue Chips Market Size, 2020-2031
6.7 South America
6.7.1 By Country – South America Artificial Tissue Chips Revenue, 2020-2031
6.7.2 By Country – South America Artificial Tissue Chips Sales, 2020-2031
6.7.3 Brazil Artificial Tissue Chips Market Size, 2020-2031
6.7.4 Argentina Artificial Tissue Chips Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Artificial Tissue Chips Revenue, 2020-2031
6.8.2 By Country – Middle East & Africa Artificial Tissue Chips Sales, 2020-2031
6.8.3 Turkey Artificial Tissue Chips Market Size, 2020-2031
6.8.4 Israel Artificial Tissue Chips Market Size, 2020-2031
6.8.5 Saudi Arabia Artificial Tissue Chips Market Size, 2020-2031
6.8.6 UAE Artificial Tissue Chips Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 Emulate
7.1.1 Emulate Company Summary
7.1.2 Emulate Business Overview
7.1.3 Emulate Artificial Tissue Chips Major Product Offerings
7.1.4 Emulate Artificial Tissue Chips Sales and Revenue in Global (2020-2025)
7.1.5 Emulate Key News & Latest Developments
7.2 TissUse
7.2.1 TissUse Company Summary
7.2.2 TissUse Business Overview
7.2.3 TissUse Artificial Tissue Chips Major Product Offerings
7.2.4 TissUse Artificial Tissue Chips Sales and Revenue in Global (2020-2025)
7.2.5 TissUse Key News & Latest Developments
7.3 Hesperos
7.3.1 Hesperos Company Summary
7.3.2 Hesperos Business Overview
7.3.3 Hesperos Artificial Tissue Chips Major Product Offerings
7.3.4 Hesperos Artificial Tissue Chips Sales and Revenue in Global (2020-2025)
7.3.5 Hesperos Key News & Latest Developments
7.4 CN Bio Innovations
7.4.1 CN Bio Innovations Company Summary
7.4.2 CN Bio Innovations Business Overview
7.4.3 CN Bio Innovations Artificial Tissue Chips Major Product Offerings
7.4.4 CN Bio Innovations Artificial Tissue Chips Sales and Revenue in Global (2020-2025)
7.4.5 CN Bio Innovations Key News & Latest Developments
7.5 Tara Biosystems
7.5.1 Tara Biosystems Company Summary
7.5.2 Tara Biosystems Business Overview
7.5.3 Tara Biosystems Artificial Tissue Chips Major Product Offerings
7.5.4 Tara Biosystems Artificial Tissue Chips Sales and Revenue in Global (2020-2025)
7.5.5 Tara Biosystems Key News & Latest Developments
7.6 Draper Laboratory
7.6.1 Draper Laboratory Company Summary
7.6.2 Draper Laboratory Business Overview
7.6.3 Draper Laboratory Artificial Tissue Chips Major Product Offerings
7.6.4 Draper Laboratory Artificial Tissue Chips Sales and Revenue in Global (2020-2025)
7.6.5 Draper Laboratory Key News & Latest Developments
7.7 Mimetas
7.7.1 Mimetas Company Summary
7.7.2 Mimetas Business Overview
7.7.3 Mimetas Artificial Tissue Chips Major Product Offerings
7.7.4 Mimetas Artificial Tissue Chips Sales and Revenue in Global (2020-2025)
7.7.5 Mimetas Key News & Latest Developments
7.8 Nortis
7.8.1 Nortis Company Summary
7.8.2 Nortis Business Overview
7.8.3 Nortis Artificial Tissue Chips Major Product Offerings
7.8.4 Nortis Artificial Tissue Chips Sales and Revenue in Global (2020-2025)
7.8.5 Nortis Key News & Latest Developments
7.9 Micronit Microtechnologies B.V.
7.9.1 Micronit Microtechnologies B.V. Company Summary
7.9.2 Micronit Microtechnologies B.V. Business Overview
7.9.3 Micronit Microtechnologies B.V. Artificial Tissue Chips Major Product Offerings
7.9.4 Micronit Microtechnologies B.V. Artificial Tissue Chips Sales and Revenue in Global (2020-2025)
7.9.5 Micronit Microtechnologies B.V. Key News & Latest Developments
7.10 Kirkstall
7.10.1 Kirkstall Company Summary
7.10.2 Kirkstall Business Overview
7.10.3 Kirkstall Artificial Tissue Chips Major Product Offerings
7.10.4 Kirkstall Artificial Tissue Chips Sales and Revenue in Global (2020-2025)
7.10.5 Kirkstall Key News & Latest Developments
7.11 Cherry Biotech SAS
7.11.1 Cherry Biotech SAS Company Summary
7.11.2 Cherry Biotech SAS Business Overview
7.11.3 Cherry Biotech SAS Artificial Tissue Chips Major Product Offerings
7.11.4 Cherry Biotech SAS Artificial Tissue Chips Sales and Revenue in Global (2020-2025)
7.11.5 Cherry Biotech SAS Key News & Latest Developments
7.12 Else Kooi Laboratory
7.12.1 Else Kooi Laboratory Company Summary
7.12.2 Else Kooi Laboratory Business Overview
7.12.3 Else Kooi Laboratory Artificial Tissue Chips Major Product Offerings
7.12.4 Else Kooi Laboratory Artificial Tissue Chips Sales and Revenue in Global (2020-2025)
7.12.5 Else Kooi Laboratory Key News & Latest Developments
8 Global Artificial Tissue Chips Production Capacity, Analysis
8.1 Global Artificial Tissue Chips Production Capacity, 2020-2031
8.2 Artificial Tissue Chips Production Capacity of Key Manufacturers in Global Market
8.3 Global Artificial Tissue Chips Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Artificial Tissue Chips Supply Chain Analysis
10.1 Artificial Tissue Chips Industry Value Chain
10.2 Artificial Tissue Chips Upstream Market
10.3 Artificial Tissue Chips Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Artificial Tissue Chips Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 DisclaimerList of Tables
Table 1. Key Players of Artificial Tissue Chips in Global Market
Table 2. Top Artificial Tissue Chips Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Artificial Tissue Chips Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Artificial Tissue Chips Revenue Share by Companies, 2020-2025
Table 5. Global Artificial Tissue Chips Sales by Companies, (K Units), 2020-2025
Table 6. Global Artificial Tissue Chips Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Artificial Tissue Chips Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Artificial Tissue Chips Product Type
Table 9. List of Global Tier 1 Artificial Tissue Chips Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Artificial Tissue Chips Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Artificial Tissue Chips Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type – Global Artificial Tissue Chips Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type – Global Artificial Tissue Chips Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type – Global Artificial Tissue Chips Sales (K Units), 2020-2025
Table 15. Segment by Type – Global Artificial Tissue Chips Sales (K Units), 2026-2031
Table 16. Segment by Application – Global Artificial Tissue Chips Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application – Global Artificial Tissue Chips Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application – Global Artificial Tissue Chips Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application – Global Artificial Tissue Chips Sales, (K Units), 2020-2025
Table 20. Segment by Application – Global Artificial Tissue Chips Sales, (K Units), 2026-2031
Table 21. By Region – Global Artificial Tissue Chips Revenue, (US$, Mn), 2025-2031
Table 22. By Region – Global Artificial Tissue Chips Revenue, (US$, Mn), 2020-2025
Table 23. By Region – Global Artificial Tissue Chips Revenue, (US$, Mn), 2026-2031
Table 24. By Region – Global Artificial Tissue Chips Sales, (K Units), 2020-2025
Table 25. By Region – Global Artificial Tissue Chips Sales, (K Units), 2026-2031
Table 26. By Country – North America Artificial Tissue Chips Revenue, (US$, Mn), 2020-2025
Table 27. By Country – North America Artificial Tissue Chips Revenue, (US$, Mn), 2026-2031
Table 28. By Country – North America Artificial Tissue Chips Sales, (K Units), 2020-2025
Table 29. By Country – North America Artificial Tissue Chips Sales, (K Units), 2026-2031
Table 30. By Country – Europe Artificial Tissue Chips Revenue, (US$, Mn), 2020-2025
Table 31. By Country – Europe Artificial Tissue Chips Revenue, (US$, Mn), 2026-2031
Table 32. By Country – Europe Artificial Tissue Chips Sales, (K Units), 2020-2025
Table 33. By Country – Europe Artificial Tissue Chips Sales, (K Units), 2026-2031
Table 34. By Region – Asia Artificial Tissue Chips Revenue, (US$, Mn), 2020-2025
Table 35. By Region – Asia Artificial Tissue Chips Revenue, (US$, Mn), 2026-2031
Table 36. By Region – Asia Artificial Tissue Chips Sales, (K Units), 2020-2025
Table 37. By Region – Asia Artificial Tissue Chips Sales, (K Units), 2026-2031
Table 38. By Country – South America Artificial Tissue Chips Revenue, (US$, Mn), 2020-2025
Table 39. By Country – South America Artificial Tissue Chips Revenue, (US$, Mn), 2026-2031
Table 40. By Country – South America Artificial Tissue Chips Sales, (K Units), 2020-2025
Table 41. By Country – South America Artificial Tissue Chips Sales, (K Units), 2026-2031
Table 42. By Country – Middle East & Africa Artificial Tissue Chips Revenue, (US$, Mn), 2020-2025
Table 43. By Country – Middle East & Africa Artificial Tissue Chips Revenue, (US$, Mn), 2026-2031
Table 44. By Country – Middle East & Africa Artificial Tissue Chips Sales, (K Units), 2020-2025
Table 45. By Country – Middle East & Africa Artificial Tissue Chips Sales, (K Units), 2026-2031
Table 46. Emulate Company Summary
Table 47. Emulate Artificial Tissue Chips Product Offerings
Table 48. Emulate Artificial Tissue Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Emulate Key News & Latest Developments
Table 50. TissUse Company Summary
Table 51. TissUse Artificial Tissue Chips Product Offerings
Table 52. TissUse Artificial Tissue Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. TissUse Key News & Latest Developments
Table 54. Hesperos Company Summary
Table 55. Hesperos Artificial Tissue Chips Product Offerings
Table 56. Hesperos Artificial Tissue Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Hesperos Key News & Latest Developments
Table 58. CN Bio Innovations Company Summary
Table 59. CN Bio Innovations Artificial Tissue Chips Product Offerings
Table 60. CN Bio Innovations Artificial Tissue Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. CN Bio Innovations Key News & Latest Developments
Table 62. Tara Biosystems Company Summary
Table 63. Tara Biosystems Artificial Tissue Chips Product Offerings
Table 64. Tara Biosystems Artificial Tissue Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Tara Biosystems Key News & Latest Developments
Table 66. Draper Laboratory Company Summary
Table 67. Draper Laboratory Artificial Tissue Chips Product Offerings
Table 68. Draper Laboratory Artificial Tissue Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Draper Laboratory Key News & Latest Developments
Table 70. Mimetas Company Summary
Table 71. Mimetas Artificial Tissue Chips Product Offerings
Table 72. Mimetas Artificial Tissue Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Mimetas Key News & Latest Developments
Table 74. Nortis Company Summary
Table 75. Nortis Artificial Tissue Chips Product Offerings
Table 76. Nortis Artificial Tissue Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Nortis Key News & Latest Developments
Table 78. Micronit Microtechnologies B.V. Company Summary
Table 79. Micronit Microtechnologies B.V. Artificial Tissue Chips Product Offerings
Table 80. Micronit Microtechnologies B.V. Artificial Tissue Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. Micronit Microtechnologies B.V. Key News & Latest Developments
Table 82. Kirkstall Company Summary
Table 83. Kirkstall Artificial Tissue Chips Product Offerings
Table 84. Kirkstall Artificial Tissue Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. Kirkstall Key News & Latest Developments
Table 86. Cherry Biotech SAS Company Summary
Table 87. Cherry Biotech SAS Artificial Tissue Chips Product Offerings
Table 88. Cherry Biotech SAS Artificial Tissue Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. Cherry Biotech SAS Key News & Latest Developments
Table 90. Else Kooi Laboratory Company Summary
Table 91. Else Kooi Laboratory Artificial Tissue Chips Product Offerings
Table 92. Else Kooi Laboratory Artificial Tissue Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. Else Kooi Laboratory Key News & Latest Developments
Table 94. Artificial Tissue Chips Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 95. Global Artificial Tissue Chips Capacity Market Share of Key Manufacturers, 2023-2025
Table 96. Global Artificial Tissue Chips Production by Region, 2020-2025 (K Units)
Table 97. Global Artificial Tissue Chips Production by Region, 2026-2031 (K Units)
Table 98. Artificial Tissue Chips Market Opportunities & Trends in Global Market
Table 99. Artificial Tissue Chips Market Drivers in Global Market
Table 100. Artificial Tissue Chips Market Restraints in Global Market
Table 101. Artificial Tissue Chips Raw Materials
Table 102. Artificial Tissue Chips Raw Materials Suppliers in Global Market
Table 103. Typical Artificial Tissue Chips Downstream
Table 104. Artificial Tissue Chips Downstream Clients in Global Market
Table 105. Artificial Tissue Chips Distributors and Sales Agents in Global Market

List of Figures
Figure 1. Artificial Tissue Chips Product Picture
Figure 2. Artificial Tissue Chips Segment by Type in 2024
Figure 3. Artificial Tissue Chips Segment by Application in 2024
Figure 4. Global Artificial Tissue Chips Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Artificial Tissue Chips Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Artificial Tissue Chips Revenue: 2020-2031 (US$, Mn)
Figure 8. Artificial Tissue Chips Sales in Global Market: 2020-2031 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Artificial Tissue Chips Revenue in 2024
Figure 10. Segment by Type – Global Artificial Tissue Chips Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type – Global Artificial Tissue Chips Revenue Market Share, 2020-2031
Figure 12. Segment by Type – Global Artificial Tissue Chips Sales Market Share, 2020-2031
Figure 13. Segment by Type – Global Artificial Tissue Chips Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global Artificial Tissue Chips Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application – Global Artificial Tissue Chips Revenue Market Share, 2020-2031
Figure 16. Segment by Application – Global Artificial Tissue Chips Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Artificial Tissue Chips Price (US$/Unit), 2020-2031
Figure 18. By Region – Global Artificial Tissue Chips Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region – Global Artificial Tissue Chips Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region – Global Artificial Tissue Chips Revenue Market Share, 2020-2031
Figure 21. By Region – Global Artificial Tissue Chips Sales Market Share, 2020-2031
Figure 22. By Country – North America Artificial Tissue Chips Revenue Market Share, 2020-2031
Figure 23. By Country – North America Artificial Tissue Chips Sales Market Share, 2020-2031
Figure 24. United States Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 27. By Country – Europe Artificial Tissue Chips Revenue Market Share, 2020-2031
Figure 28. By Country – Europe Artificial Tissue Chips Sales Market Share, 2020-2031
Figure 29. Germany Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 30. France Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 36. By Region – Asia Artificial Tissue Chips Revenue Market Share, 2020-2031
Figure 37. By Region – Asia Artificial Tissue Chips Sales Market Share, 2020-2031
Figure 38. China Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 42. India Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 43. By Country – South America Artificial Tissue Chips Revenue Market Share, 2020-2031
Figure 44. By Country – South America Artificial Tissue Chips Sales, Market Share, 2020-2031
Figure 45. Brazil Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 47. By Country – Middle East & Africa Artificial Tissue Chips Revenue, Market Share, 2020-2031
Figure 48. By Country – Middle East & Africa Artificial Tissue Chips Sales, Market Share, 2020-2031
Figure 49. Turkey Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Artificial Tissue Chips Revenue, (US$, Mn), 2020-2031
Figure 53. Global Artificial Tissue Chips Production Capacity (K Units), 2020-2031
Figure 54. The Percentage of Production Artificial Tissue Chips by Region, 2024 VS 2031
Figure 55. Artificial Tissue Chips Industry Value Chain
Figure 56. Marketing Channels

SKU: 746d7dd82114
Category:
Tags:, ,
License

, ,

Related products